|
|
|
|
LEADER |
01000caa a22002652 4500 |
001 |
ELV035342072 |
003 |
DE-627 |
005 |
20230624021908.0 |
007 |
cr uuu---uuuuu |
008 |
180603s2016 xx |||||o 00| ||eng c |
024 |
7 |
|
|a 10.1016/j.earlhumdev.2016.03.014
|2 doi
|
028 |
5 |
2 |
|a GBVA2016012000020.pica
|
035 |
|
|
|a (DE-627)ELV035342072
|
035 |
|
|
|a (ELSEVIER)S0378-3782(15)30069-4
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
082 |
0 |
|
|a 610
|
082 |
0 |
4 |
|a 610
|q DE-600
|
082 |
0 |
4 |
|a 618.3/005
|q OCLC
|
082 |
0 |
4 |
|a 610
|q VZ
|
082 |
0 |
4 |
|a 610
|q VZ
|
084 |
|
|
|a 44.45
|2 bkl
|
100 |
1 |
|
|a Ohnishi, Satoshi
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Early and intensive nutritional strategy combining parenteral and enteral feeding promotes neurodevelopment and growth at 18months of corrected age and 3years of age in extremely low birth weight infants
|
264 |
|
1 |
|c 2016
|
300 |
|
|
|a 7
|
336 |
|
|
|a nicht spezifiziert
|b zzz
|2 rdacontent
|
337 |
|
|
|a nicht spezifiziert
|b z
|2 rdamedia
|
338 |
|
|
|a nicht spezifiziert
|b zu
|2 rdacarrier
|
520 |
|
|
|a To evaluate whether aggressive nutrition can improve long-term neurodevelopmental outcomes and growth in extremely low birth weight (ELBW) infants born appropriate for gestational age (AGA).
|
700 |
1 |
|
|a Ichiba, Hiroyuki
|4 oth
|
700 |
1 |
|
|a Tanaka, Yuko
|4 oth
|
700 |
1 |
|
|a Harada, Sayaka
|4 oth
|
700 |
1 |
|
|a Matsumura, Hisako
|4 oth
|
700 |
1 |
|
|a Kan, Ayako
|4 oth
|
700 |
1 |
|
|a Asada, Yuki
|4 oth
|
700 |
1 |
|
|a Shintaku, Haruo
|4 oth
|
773 |
0 |
8 |
|i Enthalten in
|n Elsevier Science
|a Abdel-Aziz, Tarek Ezzat ELSEVIER
|t Study of serum leptin in well differentiated thyroid carcinoma: Correlation with patient and tumor characteristics
|d 2014
|g Amsterdam [u.a.]
|w (DE-627)ELV022803173
|
773 |
1 |
8 |
|g volume:100
|g year:2016
|g pages:35-41
|g extent:7
|
856 |
4 |
0 |
|u https://doi.org/10.1016/j.earlhumdev.2016.03.014
|3 Volltext
|
912 |
|
|
|a GBV_USEFLAG_U
|
912 |
|
|
|a GBV_ELV
|
912 |
|
|
|a SYSFLAG_U
|
912 |
|
|
|a SSG-OLC-PHA
|
912 |
|
|
|a GBV_ILN_130
|
912 |
|
|
|a GBV_ILN_350
|
936 |
b |
k |
|a 44.45
|j Immunologie
|q VZ
|
951 |
|
|
|a AR
|
952 |
|
|
|d 100
|j 2016
|h 35-41
|g 7
|
953 |
|
|
|2 045F
|a 610
|